CERo Therapeutics Holdings, Inc. (CERO) stock
CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%
CERo Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
CERo Therapeutics's shares outstanding was 42M at Jun 30, 2026. For fiscal 2023 it was 0M.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 42M | +24508.9% |
| Q1 FY2026 | Mar 31, 2026 | 29M | +115670.5% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +15517.8% |
| Q2 FY2025 | Jun 30, 2025 | 0M | +10664.8% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +3681.6% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +448.3% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +296.4% |
| Q3 FY2023 | Sep 30, 2023 | 0M | – |
| Q2 FY2023 | Jun 30, 2023 | 0M | – |
| Q1 FY2023 | Mar 31, 2023 | 0M | – |
| Q3 FY2021 | Sep 30, 2021 | 0M | – |
See a number that looks wrong?